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The present study explores the possible involvement of a pu-
rinergic mechanism in mechanosensory transduction in the
bladder using P2X3 receptor knock-out (P2X3
2/2) and wild-
type control (P2X3
1/1) mice. Immunohistochemistry revealed
abundant nerve ﬁbers in a suburothelial plexus in the mouse
bladder that are immunoreactive to anti-P2X3. P2X3-positive
staining was completely absent in the subepithelial plexus of
the P2X3
2/2 mice, whereas staining for calcitonin gene-related
peptide and vanilloid receptor 1 receptors remained. Using a
novel superfused mouse bladder–pelvic nerve preparation, we
detected a release of ATP proportional to the extent of bladder




2/2 bladder had an increased capacity compared with
that of the P2X3
1/1 bladder. The activity of multiﬁber pelvic
nerve afferents increased progressively during gradual bladder
distension (at a rate of 0.1 ml/min). However, the bladder affer-
ents from P2X3
2/2 mice showed an attenuated response to
bladder distension. Mouse bladder afferents of P2X3
1/1, but
not P2X3
2/2, were rapidly activated by intravesical injections of
P2X agonists (ATP or a,b-methylene ATP) and subsequently
showed an augmented response to bladder distension. By
contrast, P2X antagonists [29,39-O-(2,4,6-trinitrophenyl)-ATP
and pyridoxal 5-phosphate 6-azophenyl-29,49-disulfonic acid]
and capsaicin attenuated distension-induced discharges in
bladder afferents. These data strongly suggest a major sensory
role for urothelially released ATP acting via P2X3 receptors on a
subpopulation of pelvic afferent ﬁbers.
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The storage and periodic evacuation of urine by the bladder is
regulated by a complex neural control system that consists of the
CNS and the afferent and efferent spinal nerves. It has been
proposed that lumbosacral afferent ﬁbers (pelvic afferents) of the
urinary bladder principally regulate continence and micturition
(Kuru, 1965; de Groat and Steers, 1990). These are small myelin-
ated (Ad) and unmyelinated (C) ﬁbers that convey impulses from
bladder wall receptors. Many investigators believe that myelin-
ated sacral afferent ﬁbers are primarily involved in the nonpainful
micturition reﬂex (Bahns et al., 1986; Mallory et al., 1989),
whereas unmyelinated sacral afferents are activated under pain-
ful, pathological conditions (Ha ¨bler et al., 1990). However, the
underlying signal transduction mechanism for these afferents is
poorly understood.
There is increasing interest in the role of locally released ATP
in the bladder. Extracellular ATP has been reported to mediate
excitation of sensory neurons via P2X receptors, which are ligand-
gated ion channels. So far, seven P2X subunits (P2X1–7) have
been cloned, and six of them have been identiﬁed on sensory
neurons (Collo et al., 1996; Ralevic and Burnstock, 1998). Of
particular interest is the selective expression of P2X3 subunits on
small-diameter sensory neurons (Chen et al., 1995; Bradbury et
al., 1998) and activation by P2X agonists of afferent ﬁbers from a
variety of tissues (Bland-Ward and Humphrey, 1997; Cook et al.,
1997; Dowd et al., 1998; Hamilton et al., 2000; Rong et al., 2000).
Burnstock (1999) recently put forward a hypothesis about puri-
nergic mechanosensory transduction that proposed that in hollow
organs, including the ureter and bladder, distension causes re-
lease of ATP from epithelial cells lining these organs and that
ATP can then activate P2X3 receptors on subepithelial sensory
nerve terminals to evoke neural discharge. This is consistent with
the studies of Ferguson et al. (1997), who demonstrated release of
ATP from the serosal epithelium of rabbit bladder in response to
stretch, as well as those of Namasivayam et al. (1999) who showed
using an in vitro rat bladder preparation that prolonged exposure
to a desensitizing dose of a,b-methylene ATP (a,b-meATP)
signiﬁcantly reduced the activity of mechanosensitive pelvic
nerve afferents in response to distension. More recently, Cock-
ayne et al. (2000) demonstrated that mice lacking the P2X3
receptor gene (P2X3
2/2) had marked urinary bladder hypore-
ﬂexia with reduced voiding frequency and increased voiding vol-
ume, raising the possibility that P2X3 receptors are closely in-
volved in mechanosensory transduction underlying the activation
of afferent ﬁbers during bladder ﬁlling.
In the present study, we have further explored the sensory role
of P2X3 receptors in the urinary bladder using P2X3 receptor
knock-out (P2X3
2/2) and matching wild-type (P2X3
1/1) mice.
We aimed to (1) localize P2X3 immunoreactivity in mouse uri-
nary bladder; (2) quantify the release of ATP during graded
distensions of the mouse bladder; and (3) establish an in vitro
mouse bladder–pelvic nerve preparation and characterize the
sensory nerve response to bladder distension and purinergic
agonists.
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MATERIALS AND METHODS
Animals
Four- to six-month-old male P2X3
2/2 (27.8 6 0.4 gm) and matching
P2X3
1/1 (30.8 6 1.1 gm) mice were supplied by Roche Bioscience (Palo
Alto, CA). Details about the generation of these mice have been de-
scribed by Cockayne et al. (2000). The animals were kept and handled
according to the regulations of the United Kingdom for the use of
transgenic animals. The mice were killed by exposure to rising concen-
trations of CO2 gas.
Immunohistochemistry
P2X3 and Protein Gene Product 9.5 double labeling. The urinary bladder
was dissected, and the trigone zone of the bladder was embedded in OCT
compound (BDH/Merck, Leicester, UK) and frozen in isopentane pre-
cooled in liquid nitrogen. The tissues were sectioned at 12 mm using a
Reichert Jung CM1800 cryostat, collected on gelatin-coated slides, and
air-dried at room temperature. The slides were stored at 220°C and
allowed to return to room temperature for at least 10 min before use. The
sections were immersion-ﬁxed in 4% formaldehyde in 0.1 M phosphate
buffer for 2 min. Endogenous peroxidase was blocked by 10 min incuba-
tion in 50% methanol containing 0.4% hydrogen peroxide. Nonspeciﬁc
protein binding sites were blocked by a 20 min incubation with 10%
normal horse serum (NHS) in PBS containing 0.05% Merthiolate (Sig-
ma, Poole, UK). Sections were incubated at room temperature overnight
with P2X3 antibody (diluted to 1 mg/ml with 10% NHS). The antibody
was raised in New Zealand rabbits against a synthetic peptide corre-
sponding to the C terminus of the cloned rat P2X3 receptors (amino acid
fragment 383–397; Oglesby et al., 1999). After this incubation all washes
were performed using PBS containing 0.05% Tween 20 (Sigma). The
secondary antibody was a biotinylated donkey anti-rabbit IgG (Jackson
ImmunoResearch, Luton, UK) used at 1:500 for 1 hr, followed by
incubation with ExtrAvidin peroxidase (Sigma, Dorset, UK) diluted
1:1500 for 30 min. The tyramide signal ampliﬁcation kit (NEN Life
Science Products, Boston, MA) was applied for 8 min, followed by
incubation with Streptavidin ﬂuorescein (Amersham Pharmacia Biotech,
Bucks, UK) diluted 1:100 for 10 min. Slices were further incubated
overnight with the axon marker Protein Gene Product 9.5 (PGP 9.5;
UltraClone Ltd., Rossiters Farmhouse Wellow, UK) diluted 1:1000 in
PBS containing bovine serum albumin (BSA), lysine, Triton X-100, and
sodium azide. The secondary antibody, donkey anti-rabbit Cy3 (Jackson
ImmunoResearch) was used at a dilution of 1:400 for 1 hr. The slices
were observed under a Zeiss Axioplan microscope (Jena, Germany) at
an excitation of 520 nm (for P2X3 staining) and 570 nm (for PGP 9.5),
and images were captured by a digital camera (Leica, Germany).
Confocal microscopy. The urothelium of the isolated urinary bladder
was carefully stripped off from the smooth muscles and stretched as a
whole-mount preparation with inner surface upward on a Sylgard plate.
The tissue was ﬁxed in 4% formaldehyde at room temperature for 1 hr
and then incubated with 10% NHS to block nonspeciﬁc binding. Each
preparation was incubated overnight with one of the following antibod-
ies: anti-P2X3 (5 mg/ml), anti-vanilloid receptor 1 (VR1) (1:2000; Chemi-
con, Temecula, CA), and anti-CGRP, all diluted in PBS containing BSA,
lysine, Triton X-100, and sodium azide (all from Sigma). The secondary
antibody, biotinylated donkey anti-rabbit IgG (Jackson ImmunoRe-
search) diluted 1:500 in 1% NHS was applied for 1 hr followed by 1 hr
incubation with streptavidin FITC (Amersham Pharmacia Biotech) di-
luted 1:100. The tissue was then incubated in Pontamine Sky Blue for 5
min to reduce autoﬂuorescence. The tissue was observed under a con-
focal microscope at an excitation of 488 nm, and images were captured by
a digital camera.
In vitro urinary tract preparation and measurement of
ATP release
The whole urinary tract attached to the lower vertebrae and surrounding
tissues was quickly isolated en bloc and placed in a chamber where it was
continuously superfused with oxygenated (5% CO2 and 95% O2) Krebs’
solution (contents in mM: NaCl 120; KCl 5.9; NaH2PO4 1.2; MgSO4 1.2;
NaHCO3 15.4; CaCl2 2.5; and glucose 11.5). The chamber temperature
was kept at ;26°C. A 25 gauge needle was inserted into the lumen of the
urinary bladder and was connected to a syringe-type infusion pump
(sp210iw; World Precision Instruments, Sarasota, FL), a pressure trans-
ducer (NL108T2; Digitimer, Hertfordshire, UK), and a 100 ml Hamilton
syringe via an Omniﬁt. This enabled infusion and withdrawal of medium
(Krebs’ solutions) at a constant rate (0.1 ml/min), recording of intralu-
minal pressure, and intravesical injection of drugs. The preparation was
allowed to stabilize for at least 60 min.
ATP released from urothelial cells was measured in 100 ml samples
taken from the intravesical medium. Before each distension, four or ﬁve
samples were collected from wash-out medium at 5 min intervals (base-
line ATP levels). The bladder was distended to intraluminal pressures of
7.5, 15, 20, and 25 mmHg for 2 min at random. ATP levels were
quantiﬁed (in picomoles per milliliter) as previously described (Bodin
and Burnstock, 1996). Brieﬂy 50 ml aliquots were taken from each sample
and pipetted in duplicates onto a multi-well non-phosphorescent micro-
plate. This was placed in a luminometer (Lucyl; Anthos Labtec,
Salzburg, Austria) and processed automatically by injection of 100 ml
luciferin–luciferase reagent (Bio-Orbit, Turku, Finland) into each well.
The light emission was counted for 10 sec, and ATP concentration was
extrapolated from a calibration curve constructed using standard ATP
solutions prepared in Krebs’ solution (pH adjusted to 6 by 0.1 N HCl).
The results are presented as mean 6 SEM. Data were compared by
Student’s t test, and differences considered statistically signiﬁcant at p ,
0.05.
Electrophysiology
The mouse urinary tract was dissected and perfused as stated above.
With the aid of a dissecting microscope, a branch of the pelvic nerve
arising from the urinary bladder was dissected. The nerve activity was
recorded with a suction glass electrode (tip diameter, 50–100 mm) con-
nected to a Neurolog head stage (NL 100; Digitimer) and an AC
ampliﬁer (NL 104; Digitimer). Signals were ampliﬁed (10,0003), ﬁltered
(band-pass 200–4000 Hz), and relayed to a D310 spike processor (Digi-
timer) that discriminates neural impulses from noise with a manually set
amplitude and polarity window. The nerve activity and the intraluminal
pressure were recorded on tape and a computer with a power 1401
analog-to-digital interface and Spike2 software (Cambridge Electronic
Design, Cambridge, UK). The nerve activity was counted and plotted as
rate histogram.
In pilot studies, the characteristics of neuronal response to bladder
distension and the stability of the model was tested by repeatedly ﬁlling
the bladder with Krebs’ solution at a rate of 0.1 ml/min and at intervals
of 10–15 min. Consistent neuronal response to distension could be
obtained for as long as 10 hr. To quantify the changes in nerve activity
in response to bladder distension, each preparation was ﬁrst distended at
a rate of 0.1 ml/min until the nerve activity reached a plateau (control
maximal activity), and this was repeated three times (interval between
distension 5 10 min). The average ﬁring rate in every 15 sec period (i.e.,
for every 25 ml of injected volume) was counted, expressed as a percent-
age of the maximal activity (normalized nerve activity), and plotted
against the volume of medium in the bladder. The effects of P2X agonists
on the pelvic afferents and their response to distension were tested by
injecting 0.1 ml solutions containing the agonists as a bolus into the
empty bladder and distending the bladder 10 min thereafter. The effects
of P2X antagonists and capsaicin were examined using a similar protocol.
Chemicals
ATP (disodium salt), a,b-meATP (lithium salt,), and pyridoxal
5-phosphate 6-azophenyl-29,49-disulfonic acid (PPADS) (all obtained from
Sigma, St. Louis, MO) were diluted to ﬁnal concentrations in Krebs’
solution, and the pH was adjusted to 7.4. Capsaicin (Tocris Cookson,
Bristol, UK) was dissolved in DMSO as a 10 mM stock solution and diluted
to ﬁnal concentrations in Krebs’ solution before use. All inorganic salts
were purchased from BDH Laboratory Supplies (Poole, UK).
RESULTS
Immunohistochemical characterization of bladder
sensory afferents
As illustrated in Figure 1, A and D, intense immunoﬂuorescent
staining for P2X3 subunits was found in nerve bundles between
the smooth muscle layer of the bladder wall in P2X3
1/1, but not
in P2X3
2/2 mice. However, staining for PGP 9.5, an axon
marker, was found in the bladder from both P2X3
1/1 and
P2X3
2/2 mice (Fig. 1B,E). The staining for P2X3 subunits coex-
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1/1, but not in the
P2X3
2/2 mouse bladder (Fig. 1C,F).
Whole-mount bladder urothelial preparations examined with
confocal microscopy revealed a dense suburothelial plexus of
CGRP-immunoreactive nerve ﬁbers in P2X3
1/1 as well as
P2X3
2/2 mice (Fig. 2A,D). Similarly, VR1-immunoreactive ﬁ-
bers (Fig. 2B,E) were also found in the suburothelial plexus from
both P2X3
1/1 and P2X3
2/2 mice. Although numerous P2X3-
positive ﬁbers were found in the suburothelial plexus and in those
projections between urothelial cells in the bladder of P2X3
1/1
mice (Fig. 2C), none were seen in the suburothelial plexus of
P2X3
2/2 mice (Fig. 2F).
Distension-induced ATP release from the urothelium
The bladder was distended by intravesical infusion of Krebs’
solution at a constant rate (0.1 ml/min) until the intraluminal
pressure reached a certain level. It was noticed that the bladders
of P2X3
2/2 mice typically had a larger capacity than those of
P2X3
1/1 mice such that the same levels of intravesical pressure
could be achieved after infusion of larger volumes of medium. In
bladders from P2X3
1/1 mice, 7.5 mmHg was achieved with 110 6
5 ml medium, 15 mmHg with 215 6 10 ml, 20 mmHg with 320 6
20 ml, and 25 mmHg with 430 6 15 ml. In bladders from P2X3
2/2
mice, the same intravesical pressure was produced by infusion
of 135 6 15, 245 6 15, 360 6 20, and 480 6 25 ml, respectively.
The basal release of ATP was measured in the samples taken
from the medium during every predistension period. The base-
line levels of ATP were similarly low during all predistension
periods in both P2X3
1/1 and P2X3
2/2 mice, being 0.5 6 0.1
and 0.6 6 0.1 pmol/ml, respectively. The threshold for
distension-evoked ATP release was 3.5–4.0 mmHg, which cor-
responded to intravesical volume of 60–70 ml for the P2X3
1/1
mouse bladder. With increasing intravesical volume (and pres-
sure), ATP level increased progressively. Thus, distension to
an intravesical pressure of 7.5 mmHg produced a several-fold
incremental increase of ATP over the baseline level. The
plateau of intravesical ATP levels was reached at an intraves-
ical pressure of 20 mmHg, which corresponded to intravesical
volume of 300 6 20 ml. Distension of P2X3
2/2 bladder pro-
duced an identical pattern of ATP release. The results of this
series of experiments are summarized in Table 1.
Figure 1. Double staining for P2X3 and
PGP 9.5 in the mouse urinary bladder.
Top and bottom panels are sections of
the bladder (with all layers of the blad-
der wall) from P2X3 wild-type
(P2X3
1/1) and P2X3 knock-out mice
(P2X3
2/2), respectively. A, D, Immuno-
ﬂuorescence ( green) for P2X3 receptor.
Note that the nerve bundle within the
smooth muscle coat is densely stained
for the P2X3 subunit. B, E, immunoﬂu-
orescence (red) for PGP 9.5, an axon
marker. C, F, Co-staining for P2X3 and
PGP 9.5. L, Luminal side of the bladder
wall; S, serosal side of the bladder wall;
M, smooth muscle. Scale bar, 100 mm.
Figure 2. Immunostaining of the sub-
epithelial sensory nerve plexus in the
mouse bladder. Each panel represents
the inner surface of a small piece of
urothelium (clear of smooth muscles).
Top and bottom panels are urothelium
from P2X3 wild-type (P2X3
1/1) and
P2X3 knock-out mice (P2X3
2/2), re-
spectively. A, D, Immunoﬂuorescence
for CGRP; B, E, Immunoﬂuorescence
for VR1; C, F, Immunoﬂuorescence for
P2X3 subunits. Scale bar, 100 mm.
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of the bladder and P2X agonists
The pelvic afferent ﬁbers from the urinary bladder of P2X3
1/1
and P2X3
2/2 mice both had low background activity (0–10
spikes/sec). Examples of distension-induced changes in intraves-
ical pressure and discharges in pelvic afferents in bladder–pelvic
nerve preparations from P2X3
1/1 and P2X3
2/2 mice are illus-
trated in Figure 3. Figure 4 summarizes the data from this series
of experiments. In most preparations, biphasic activation of af-
ferent ﬁbers in association with increases in intravesical pressure
was observed with an initial slow rise followed by a later rapid
increase in pressure and nerve activity. However, the pelvic
afferents of P2X3
2/2 mice were less sensitive to bladder disten-
sion than those of P2X3
1/1 mice (Fig. 3, compare A, B). In the
P2X3
1/1 mice, nerve activity started to increase when the blad-
der was distended to a volume of 115.6 6 11.6 ml (intravesical
pressure of 5.7 6 1.0 mmHg; n 5 8), whereas in the P2X3
2/2
mice, the threshold for signiﬁcant increase in nerve activity was
276.7 6 24.0 ml (intravesical pressure of 10.2 6 1.6 mmHg; n 5 6)
(Fig. 4). In P2X3
1/1 mice, nerve activity reached a peak when the
bladder was distended to a volume of 472.6 6 51.8 ml (intravesical
pressure of 36.1 6 4.7 mmHg; n 5 8), whereas in the P2X3
2/2
mice, peak nerve activity was achieved at signiﬁcantly larger
intravesical volumes (729.1 6 57.3 ml, corresponding to a pressure
of 40.5 6 6.1 mmHg; n 5 6) (Fig. 4).
The effects of P2X agonists (a,b-meATP and ATP) and cap-
saicin on the pelvic afferents of P2X3
1/1 mice (n 5 7) and
P2X3
2/2 mice (n 5 5) are shown in Figure 5. The agonists were
injected into the empty bladder as a 100 ml bolus. Injecting 100 ml
of vehicle into the bladder did not evoke signiﬁcant changes in
intravesical pressure and nerve activity. In the P2X3
1/1 mice
(Fig. 5A1), a,b-meATP (100–300 mM) induced a rapid increase in
the discharge of the pelvic afferents, and the response lasted for
5–10 min. Similarly, ATP (Fig. 5B1) induced a rapid excitation of
the pelvic afferents, but the minimal concentration of ATP (1
mM) required to evoke a signiﬁcant neural response was ;10-fold
higher than that of a,b-meATP (100 mM). Neither ATP nor
a,b-meATP had any signiﬁcant effect on the activity of the pelvic
nerve of the P2X3
2/2 mice (Fig. 5A2,B2). However, capsaicin (30
mM) induced signiﬁcant afferent activation in both P2X3
1/1 and
P2X3
2/2 preparations. All these agonists also produced similar
small increases in intravesical pressure in both P2X3
1/1 (Fig.
5C1) and P2X3
2/2 (Fig. 5C2) preparations.
The effects of a,b-meATP and capsaicin agonists on the affer-
ent nerve response to distension were further examined by dis-
tending the bladder 10 min after the administration of the ago-
nists. As demonstrated in Figures 6 and 7, a,b-meATP did not
affect the pressure changes during distension. However, in
P2X3
1/1 preparations the afferent nerve response to distension
was greatly potentiated by preinfusion of agonist, in that nerve
activity increased faster and reached a greater peak level than
that observed with vehicle alone (Figs. 6, 7). Recovery of the
distension-induced afferent nerve responses was achieved after
washout of the agonist. The potentiation was not seen in the
P2X3
2/2 preparation (n 5 2). In contrast, after administration of
capsaicin, the afferent nerve response to bladder distension was
Table 1. Distension-induced release of ATP in P2X3 wild-type and P2X3
knock-out mouse urinary bladder
Intravesical
pressure
Release of ATP (pmol/ml)
P2X3 wild-type P2X3 knock-out
Basal pressure 0.5 6 0.1 (15) 0.6 6 0.1 (4)
7.5 mmHg 4.1 6 1.0** (15) 3.6 6 1.8* (3)
15 mmHg 10.7 6 1.9** (11) 11.6 6 3.8* (4)
20 mmHg 20.8 6 3.2** (10) 21.9 6 6.6* (3)
25 mmHg 20.9 6 3.2** (4) 21.9 6 3.2* (4)
*p , 0.05 and **p , 0.001 versus basal release (Student’s t test). In parentheses are
the number of animals.
Figure 3. Distension-induced discharges in mouse bladder afferents. A,
Wild-type mice (P2X3
1/1). B, P2X3 knock-out mice (P2X3
2/2). The
bladder was distended at a constant rate of 0.1 ml/min. Note the much
delayed activation of the bladder afferents in the P2X3
2/2 preparation.
Figure 4. A summary of the alterations in intravesical pressure and
bladder afferent activity during distension of the bladder. The nerve
activity was normalized and expressed as the percentage of maximal
activity. Data representative of an n 5 8 for P2X3-wild type mice
(P2X3
1/1) and an n 5 6 for P2X3-knock-out mice (P2X3
2/2).
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(n 5 5; p , 0.01) of the control.
The neural response to P2X agonists in the P2X3
1/1 control
mice could be blocked by the P2X antagonists PPADS (n 5 4)
and 29,39-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP) (n 5 4). This
is exempliﬁed in Figure 8, which illustrates the attenuation in
nerve activity induced by intravesical injection of a,b-meATP
after, but not before, preincubating the preparation intravesically
with TNP-ATP (Fig. 8, compare A, B). Both PPADS and TNP-
ATP were also able to reduce the neural response to bladder
distension with a representative recording shown in Figure 9.
Distension-induced peak activity was reduced after pretreatment
with TNP-ATP (30 mM) and PPADS (300 mM) to 65.3 6 18.4%
(n 5 4; p , 0.05) and 47.1 6 17.3% (n 5 4; p , 0.01) of the
vehicle control, respectively.
DISCUSSION
Morphology of the sensory innervation of the bladder
The major function of the urinary bladder is to store and evac-
uate urine. The signiﬁcance of the sensory innervation of the
bladder is to detect the ﬁlling of the bladder and convey this
information to the CNS to evoke the micturition reﬂex. The
innocuous sensory information about bladder fullness is trans-
formed to a painful sensation (or discomfort) when the intraves-
ical pressure reaches a threshold of 30–50 mmHg (Ha ¨bler et al.,
1990). Two types of afferent ﬁbers are involved, namely myelin-
ated Ad- and unmyelinated C-afferent ﬁbers of the pelvic and the
hypogastric nerves (McGuire, 1986), which comprise low- and
high-threshold mechanosensory receptors (Sengupta and Geb-
hart, 1994). Detailed immunohistochemical (CGRP) and immu-
noﬂuorescent (synaptophysin) studies have revealed dense plex-
uses of afferent axons in a close apposition to the urothelium
(Gabella and Davis, 1998). The afferent axons were shown to be
associated with four major targets: the base of the urothelium, the
space between urothelial cells, blood capillaries, and smooth
Figure 5. Responses of multiﬁber bladder afferents to intravesical ad-
ministration of P2X agonists and capsaicin. Left, Wild-type control mice
(P2X3
1/1). Right, P2X3 knock-out mice (P2X3
2/2). Agonists (a,b-
meATP, 100 mM;A T P ,1m M; capsaicin, 30 mM) were injected into the
empty bladder in a volume of 100 ml. All recordings on the left column are
from same P2X3
1/1 mouse, and those on the right column are from same
P2X3
2/2 mouse.
Figure 6. Effects of a,b-meATP on the distension-induced changes in
multiﬁber bladder afferent activity in a P2X3 wild-type (P2X3
1/1) mouse.
A and B are sequential recordings in same preparation. In A, an injection
of vehicle (Krebs’, 0.1 ml) was followed by bladder distension (0.1 ml/
min). In B, distension (0.1 ml/min) was preceded by an injection of
a,b-meATP (0.3 mM, 0.1 ml), which itself elicited afferent discharges and
potentiated distension-induced discharges.
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tween urothelial cells or in the suburothelial plexus adjacent to
the basal surface of urothelium. Immunohistochemical studies
have revealed that although the detrusor muscle expresses P2X1
receptors (Ferguson, 1999; Lee et al., 2000), P2X3 receptors are
present in the urothelium (Ferguson, 1999) and speciﬁcally on
afferent nerve ﬁbers (Cockayne et al., 2000). In agreement with
these data, we found abundant CGRP, VR1, and P2X3 receptor-
immunoreactive nerve ﬁbers running between urothelial cells, in
the suburothelial plexus, and perivascularly in the urinary bladder
of P2X3
1/1 mouse (Fig. 2). P2X3 immunostaining coexists with
staining for the neuronal marker PGP 9.5 (Fig. 1), indicating the
neuronal localization of P2X3 receptors. As expected, P2X3 re-
ceptor immunoreactivity was completely absent in the bladder of
P2X3
2/2 mice, but the immunoreactivity for CGRP and VR1
seemed unaltered (Fig. 2). The importance of the P2X3-positive
afferents in sensory signal transduction in the bladder is signiﬁed
by the ﬁndings of Cockayne et al. (2000) that P2X3-deﬁcient mice
display marked urinary bladder hyporeﬂexia.
Distension induced release of ATP from the bladder
In a rabbit bladder preparation, Ferguson et al. (1997) recorded
changes in short-circuit currents and transepithelial potential that
were accompanied by a substantial release of ATP from the
serosal, but not luminal side of the urothelium in response to
stretch. It was suggested that urothelium was a sensor for pressure
in the bladder, which released ATP through nonvesicular mech-
anisms. In the present study, we detected a signiﬁcant release of
ATP into the lumen during distension of the mouse urinary
bladder. In normal control mice, the threshold for the release of
ATP was 3.5–4.0 mmHg of intravesical pressure, indicating that
innocuous ﬁlling of the bladder may evoke release of ATP. We
further demonstrated that distension-induced release of ATP is
preserved in P2X3
2/2 mice.
Electrical activity of the pelvic nerve ﬁbers from
the bladder
The electrophysiological properties of sensory innervation in the
lower urinary tract have been studied extensively in the rat
(Mallory et al., 1989) and cat in vivo (Bahns et al., 1986; Janig and
Morrison, 1986; Ha ¨bler et al., 1990) and more recently in the rat
Figure 7. A summary of the effects of a,b-meATP on distension-induced
changes in bladder afferent activity in P2X3 wild-type (P2X3
1/1) mice.
The experimental protocol was the same as shown in Figure 6. The nerve
activity was normalized and expressed as a percentage of the maximal
ﬁring rate reached during the control distension with vehicle. Data were
pooled from six P2X3
1/1 mouse bladder–nerve preparations.
Figure 8. Effects of TNP-ATP on bladder afferent responses to
a,b-meATP. A, An intravesical injection of a,b-meATP (100 mM, 0.1 ml)
induced signiﬁcant discharges in the bladder afferents. B, The preparation
was incubated intravesically with the P2X antagonist TNP-ATP (30 mM,
0.1 ml) for 10 min; a subsequent injection of a,b-meATP (100 mM, 0.1 ml)
after removal of the TNP-ATP produced little change in nerve activity.
Figure 9. Effects of PPADS on the distension induced changes in bladder
afferent activity in a P2X3 wild-type (P2X3
1/1) mouse bladder–nerve
preparation. A, Nerve activity in control situation. B, Nerve activity after
application of PPADS (300 mM).
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been a neglected species in the study of neural control of the
urinary tract, and little is known about the functional properties
of afferent nerves from the mouse bladder. However, with more
transgenic mice becoming available, this species is becoming an
increasingly important experimental animal in bridging the infor-
mation from molecular biology and systems physiology. In this
paper, we describe a novel in vitro mouse bladder–pelvic nerve
preparation. Using this model, we have, for the ﬁrst time, exam-
ined the characteristics of the pelvic afferent response to bladder
distension. The response consists of a progressive increase in
ﬁring rate in association with rises in intravesical pressure. Our
observations indicate that this preparation is a relatively simple
and reliable model for investigating sensory signal transduction
mechanisms in the urinary bladder.
Namasivayam et al. (1999) recently reported the use of an in
vitro rat bladder–pelvic nerve preparation to demonstrate that
distension induced by an intravesical infusion of a solution con-
taining 10 mM a,b-meATP produced slightly greater responses at
ﬁrst and then signiﬁcantly attenuated responses in pelvic affer-
ents. These effects of a,b-meATP were attributed to the activa-
tion and subsequent desensitization of P2X receptors located on
afferent terminals on the urinary bladder. In support of this
concept, we have localized P2X3 receptor immunoreactivity on
afferent nerve ﬁbers located in the mouse urinary bladder. Our
electrophysiological observations demonstrate that intravesical
applications of P2X agonists (ATP or a,b-meATP) induce a rapid
excitation of bladder afferents in the P2X3
1/1 mice. Furthermore,
a,b-meATP greatly potentiated subsequent distension-induced
afferent discharges. This seems to contradict the observations of
Namasivayam et al. (1999). However, this discrepancy may be
attributable to the difference in the concentration and the speed
of delivery of the agonist. Although we injected a,b-meATP
(100–300 mM, 0.1 ml) into the bladder as a bolus, they distended
the bladder slowly with a,b-meATP (10 mM).
A signiﬁcant change in electrophysiological properties of blad-
der afferents in P2X3
2/2 mice is their diminished response to
P2X agonists (Fig. 5) and their attenuated response to bladder
distension, which was manifested by a signiﬁcantly delayed and
increased threshold of activation of the afferents when compared
with those from P2X3
1/1 mice (Figs. 3, 4). This strongly indicates
that P2X3 subunits on afferent terminals may play an important
part in mechanosensory transduction in the urinary bladder.
However, as illustrated in Figure 4, P2X3
2/2 bladder generates
less intravesical pressure for a given distension. On one hand, this
is not unexpected if mechanosensory transduction in the bladder
involves a purinergic component of P2X3 subunits—a deﬁciency
of which may lead to increased threshold for micturition and
consequently compensatory increase in bladder capacity. On the
other hand, it is likely that this reduced bladder pressure response
(or increased bladder capacity) in the P2X3
2/2 mice may also
partially account for the attenuated nerve response to bladder
distension.
Previous studies indicate that there may be different functional
classes of bladder afferents. Ad afferents in the cat respond in a
graded manner to distension of the bladder (Janig and Morrison,
1986) and are activated by noxious stimuli as well. On the other
hand, C ﬁbers in the cat have very high mechanical thresholds and
commonly do not respond to even high levels of intravesical
pressure (Ha ¨bler et al., 1990). The activity in some of these
afferents, however, is triggered by chemical irritation of the
bladder mucosa (Ha ¨bler et al., 1990) or cold (Fall et al., 1990).
Single-unit studies will be necessary to determine whether a
purinergic mechanism preferentially modulates the sensory trans-
duction in one of the different classes of bladder afferents.
In other organs, capsaicin has been used to differentiate be-
tween innocuous and nociceptive (Ad and C) ﬁbers. However,
whereas afferents from the bladder consist largely of Ad and C
ﬁbers, both are activated by capsaicin. In the present study cap-
saicin was able to signiﬁcantly attenuate afferent response to
distension and intravesical administration of P2X agonists. This
is consistent with the immunohistochemical colocalization of
P2X3 and VR1 receptors in afferent nerve ﬁbers. Interestingly,
rats treated with capsaicin as neonates were found to excrete less
urine (Holzer-Petsche and Lembeck, 1984). Their bladders were
found to have a larger capacity (5 ml) than normal controls (1 ml),
and systemic capsaicin treatment was able to block the rhythmic
contraction of detrusor muscles in response to distension. Clini-
cally, intravesical administration of capsaicin has been proven
effective in treating incontinence (Chancellor and de Groat,
1999). Given that P2X agonists and capsaicin can affect the
activity of the same set of afferent ﬁbers, P2X3 agonists/antago-
nists may be of therapeutic use in urological conditions arising
from disorders affecting the sensory mechanisms in the bladder.
In summary, we have demonstrated the presence of P2X3
receptors on afferent nerve ﬁbers closely associated with the
urothelium and the release of ATP by distension of the mouse
urinary bladder in a novel in vitro mouse bladder–pelvic nerve
preparation. We found that P2X agonists were able to activate
pelvic afferents and potentiate their response to bladder disten-
sion in P2X3
1/1, but not in P2X3
2/2 mice that showed attenu-
ated pelvic afferent response to bladder distension. These data
strongly suggest a major sensory role of urothelially released ATP
via activation of P2X3 receptors on a subpopulation of pelvic
afferent nerve ﬁbers.
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